SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lin Mei, Evelena P. Ontiveros, Elizabeth A. Griffiths, James E. Thompson, Eunice S. Wang, Meir Wetzler, Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy, Blood Reviews, 2015,

    CrossRef

  2. 2
    Henry M. Dunnenberger, Kristine R. Crews, James M. Hoffman, Kelly E. Caudle, Ulrich Broeckel, Scott C. Howard, Robert J. Hunkler, Teri E. Klein, William E. Evans, Mary V. Relling, Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers, Annual Review of Pharmacology and Toxicology, 2015, 55, 1, 89

    CrossRef

  3. 3
    Joseph C Maranville, Anna Di Rienzo, Combining genetic and nongenetic biomarkers to realize the promise of pharmacogenomics for inflammatory diseases, Pharmacogenomics, 2014, 15, 15, 1931

    CrossRef

  4. 4
    Aniwaa Owusu-Obeng, Kristin W. Weitzel, Randy C. Hatton, Benjamin J. Staley, Jennifer Ashton, Rhonda M. Cooper-Dehoff, Julie A. Johnson, Emerging Roles for Pharmacists in Clinical Implementation of Pharmacogenomics, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2014, 34, 10
  5. 5
    Ching-Hon Pui, Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia, Frontiers of Medicine, 2014,

    CrossRef

  6. 6
    Paul Christiaan Bank, Joachim Jesse Swen, Henk-Jan Guchelaar, Pharmacogenetic biomarkers for predicting drug response, Expert Review of Molecular Diagnostics, 2014, 14, 6, 723

    CrossRef

  7. 7
    Susanne B Haga, Nancy M Allen LaPointe, Jivan Moaddeb, Rachel Mills, Mahesh Patel, William E Kraus, Pilot study: incorporation of pharmacogenetic testing in medication therapy management services, Pharmacogenomics, 2014, 15, 14, 1729

    CrossRef